By Gage Skidmore from Surprise, AZ, United States of America - Robert F. Kennedy, Jr., CC BY-SA 2.0,
For decades, Americans were told a story about their health that no longer matched reality. We were assured that food was safe, that regulators were vigilant, that medical advice was insulated from politics and profit, and that rising chronic disease was an unfortunate but unavoidable byproduct of modern life. Meanwhile, the health of the nation deteriorated in plain sight. Obesity climbed year after year. Childhood chronic disease became common rather than exceptional. Autism rates surged. Cancer diagnoses among children rose. By the time President Trump returned to office, 76.4% of Americans were living with at least one chronic disease. Eight out of 10 children could not qualify for military service. What should have been treated as a civilizational emergency was instead normalized, until that long-running failure of honesty and accountability culminated during the COVID-19 pandemic, when public health leaders abandoned transparency, misled the public, and, under Dr. Fauci’s direction, shattered trust in medical professionals and the institutions meant to serve them.
The collapse of trust that followed COVID did not occur in a vacuum. It was the culmination of years of regulatory capture, scientific arrogance, and a public health establishment that confused authority with truth. Americans were ordered, not persuaded. Dissent was pathologized. Data was selectively presented. Vaccine policy was enforced through mandate rather than transparency. Dr. Fauci became the symbol of an anti-science regime that claimed infallibility while revising its claims in real time. When institutions insist on obedience while refusing accountability, trust does not merely erode; it implodes.
MEASLES: Despite years of unprecedented legal and illegal migration, the US has measles under control compared to peer nations. Canada now has nearly 20X the US case rate, while the UK has roughly triple. Vaccine hesitancy driven by exposed Covid falsehoods is hitting countries… pic.twitter.com/dRfMJrf3J9
It is against this backdrop that the Make America Healthy Again initiative must be understood. MAHA is not a branding exercise or a partisan slogan. It is a course correction. President Trump’s decision to place Robert F. Kennedy Jr. at the helm of HHS was not an appeal to nostalgia or name recognition. It was an explicit rejection of the managerial consensus that presided over the chronic disease explosion. The mandate was simple and radical: identify root causes, dismantle regulatory capture, and tell the truth even when it disrupts powerful interests.
Skeptics ask whether one year can matter. The answer depends on what one expects a first year to do. MAHA was never going to reverse decades of metabolic, environmental, and institutional decay overnight. Its purpose was to reorient the system, establish credibility, and force long-delayed questions back into the open. By that standard, the first year has been historic.
Start with the scope of institutional change. President Trump signed an executive order establishing the MAHA Commission, chaired by Secretary Kennedy, with a singular focus on chronic disease. For the first time in generations, chronic illness was treated not as an actuarial inevitability but as a policy failure demanding investigation. This alone marked a break with orthodoxy. Under previous administrations, chronic disease spending rose to $1.3T annually while prevention remained an afterthought. When Kennedy notes that the federal government once spent essentially nothing on chronic disease, he is not making a rhetorical point. He is diagnosing a structural blind spot.
The results are already visible. Thirty-seven states have enacted legislation advancing MAHA-aligned reforms. Nearly 100 MAHA-related bills have passed nationwide. Eighteen states secured SNAP waivers to restrict taxpayer-funded junk food purchases that directly fuel obesity and diabetes. These are not symbolic victories. They are structural incentives aligned with public health rather than industry convenience.
Food policy has been the most visible arena of reform, and for good reason. The American diet did not become toxic by accident. It was engineered through regulatory loopholes that allowed synthetic additives to enter the food supply under the GRAS standard with minimal oversight. MAHA moved quickly to overhaul this system. Agreements now cover roughly 40% of the food industry, committing to remove petroleum-based synthetic dyes. The dairy industry has pledged to eliminate artificial dyes from ice cream by 2028. These changes matter because they reset norms. Once voluntary reform becomes expected, resistance collapses.
The same logic applies to infant health. Operation Stork Speed was launched to expand access to safe and nutritious infant formula while removing heavy metals that had no business entering baby food in the first place. For parents who watched institutions minimize legitimate safety concerns during COVID, this shift toward precaution and transparency has been decisive in rebuilding trust.
Critics often ask whether MAHA is anti-science. The premise is backward. MAHA is anti-dogma. It insists that science earns authority through openness, replication, and humility. This is why vaccine policy has been reframed around informed consent and gold standard trials rather than mandates. Honesty about uncertainty is not weakness. It is the precondition of credibility. Public trust returns when institutions stop pretending to be omniscient.
This emphasis on trust extends beyond food and vaccines. HHS issued guidance restoring biological truth, recognizing that there are two sexes, male and female. This was not culture war theater. Medicine depends on biological reality. When institutions deny observable facts for ideological reasons, patients notice. Restoring clarity restores confidence.
MAHA’s critics also underestimate the importance of state-level experimentation. Utah’s decision to ban added fluoride in public drinking water did not impose a national mandate. It reopened a conversation that had been closed by bureaucratic inertia. Communities are once again allowed to weigh risks and benefits rather than defer to outdated consensus.
Health care delivery itself has not been ignored. Prior authorization has long functioned as a hidden tax on patients and physicians, delaying care while enriching intermediaries. Secretary Kennedy and CMS Administrator Oz secured industry commitments to streamline this process across health plans. Less paperwork means faster treatment and lower burnout. These are the reforms patients feel immediately.
Drug pricing has followed the same philosophy. President Trump’s most favored nation order is being rapidly implemented to align U.S. prescription drug prices with those paid abroad. This is not price control masquerading as populism. It is a refusal to subsidize global markets at the expense of American patients. Lower prices are a public health intervention.
Physical health has returned to the cultural mainstream as well. The Pete and Bobby Challenge, launched by Secretary Kennedy alongside Defense Secretary Hegseth, did something that countless white papers failed to do. It made fitness visible again. A nation where most children cannot meet basic physical standards is not merely unhealthy. It is vulnerable.
The MAHA Commission’s release of the Make Our Children Healthy Again strategy, outlining more than 120 initiatives, signaled that childhood chronic disease is no longer being treated as a mystery or a taboo. New data linking rising thyroid and kidney cancers among children demands answers. Autism rates demand answers. MAHA has made clear that asking these questions is not forbidden. It is required.
Perhaps the most underestimated achievement of the first year is cultural rather than regulatory. Trust is returning because institutions are speaking plainly. The public understands that special interests once thrived behind closed doors. They know they were sold better cigarettes and sugar smacks with a health halo. What they demanded in 2024 was not perfection. It was honesty.
President Trump and Secretary Kennedy have delivered the first credible attempt in decades to dismantle the alliance between bureaucratic power and corporate profit that hollowed out public health. The appointments at NIH, FDA, and CMS reflect this shift. These are not partisan enforcers. They are reformers tasked with ending capture and restoring the mission.
No serious observer should claim that the work is finished. Chronic disease did not emerge in one year, and it will not be eliminated in one term. But trajectories matter. Incentives matter. Trust matters most of all. After years in which Americans were told to comply and not question, MAHA has reopened the social contract between the public and medicine.
Public health cannot function without consent. Consent requires trust. Trust requires truth. That is the chain MAHA is rebuilding. It is why the first year matters. Not because every problem has been solved, but because the system has finally been pointed in the right direction.
Sponsored by the John Milton Freedom Foundation, a nonprofit dedicated to helping independent journalists overcome formidable challenges in today’s media landscape and bring crucial stories to you.
Vanessa Trump is moving forward with optimism as she continues her battle with breast cancer.
The former wife of Donald Trump Jr. shared a heartfelt update with supporters Saturday, revealing that she has spent the past several weeks recovering from surgery and is preparing to begin the next phase of her treatment.
“I wanted to share an update on my cancer journey,” Trump wrote in an Instagram post. “Over the past four weeks, I’ve been recovering from surgery and I’m grateful to be healing and moving forward. Soon, I’ll be starting the second stage of my treatment. Sending love, strength, and hope to everyone fighting this battle.”
Vanessa first revealed her diagnosis publicly on May 20, telling followers that she was focused on her health and recovery while surrounded by loved ones. At the time, she briefly referenced an upcoming medical procedure but chose not to disclose many details about her treatment plan.
In Saturday’s update, Trump did not elaborate on the surgery or the next stage of treatment. Instead, she emphasized gratitude and the support system helping her through the difficult journey.
“I am staying focused and hopeful while surrounded by the love and support of my family, my kids, and those closest to me,” she previously wrote, adding, “I kindly ask for privacy as I focus on my health and recovery.”
The update prompted an outpouring of support from friends, family members, and followers. Ivanka Trump publicly shared her encouragement, writing, “Praying for your continued strength and a swift recovery. Love you mama.”
Vanessa and Donald Trump Jr. were married for more than a decade and share five children together: Kai, Donald III, Tristan, Spencer, and Chloe. Though the couple divorced in 2018, they have remained committed co-parents, frequently appearing together at family milestones and supporting their children’s activities.
The latest health update comes during a busy season for the extended Trump family. Just weeks ago, Donald Trump Jr. married Bettina Anderson during a ceremony in the Bahamas over Memorial Day weekend, bringing together family and friends for the celebration.
Meanwhile, Vanessa’s relationship with golf icon Tiger Woods has also drawn public attention in recent months. The pair have largely kept their romance private, though reports have suggested Woods has remained supportive as Vanessa navigates treatment and recovery.
For now, Vanessa appears focused on her health, her family, and the road ahead — while continuing to receive support from those closest to her as she begins the next chapter of treatment.
Lee made the remarks when asked about McConnell’s prolonged absence from the Senate, saying rank-and-file lawmakers have received few details beyond the limited public statements released by McConnell’s office.
‘Most Of Us Don’t Know’
Lee acknowledged that speculation has grown because so little official information has been released.
His comments contrast with earlier remarks from Senate Majority Leader John Thune, who previously said McConnell “sounded good” during a recent conversation. Lee indicated that most senators have not received similar updates and remain largely in the dark about their colleague’s condition.
Office Continues To Release Limited Information
McConnell’s office has consistently maintained that the 84-year-old senator is recovering and remains engaged with Senate business.
In its latest public statement, spokesman David Popp said McConnell “continues to improve” and is working with staff on Kentucky and Senate matters while Congress is in recess. The office has not disclosed his diagnosis, prognosis, or expected discharge date.
Medical Emergency Prompted Questions
McConnell has not appeared publicly since June 14, when emergency responders were dispatched to his Washington residence.
Emergency dispatch audio reviewed by multiple news organizations described an unconscious patient and referenced CPR in progress. McConnell’s office has not confirmed the specific medical event that led to his hospitalization.
The absence of detailed updates has fueled intense online speculation, including unverified claims promoted by White House confidant Laura Loomer. McConnell’s office has offered no support for those assertions, saying only that the senator continues to improve.
Questions Persist As Senate Recess Continues
The Senate remains in recess until later this month, giving McConnell additional time to recover before lawmakers return to Washington.
Whether he will be able to resume his duties when the Senate reconvenes remains unclear. McConnell previously announced he will not seek reelection and plans to retire when his current term expires in January 2027.
For now, Lee’s comments highlight what many senators have acknowledged privately: beyond the brief statements released by McConnell’s aides, even many of his Republican colleagues say they know little about his current condition.
The U.S. Senate has confirmed Robert F. Kennedy Jr. as the next Secretary of Health and Human Services (HHS) following weeks of debate over his nomination.
Once again, Sen. Mitch McConnell (R-Ky.) stood alone as the only Republican to vote against President Trump’s nominee. McConnell opposed Tulsi Gabbard’s nomination as director of national intelligence (DNI).
🚨🚨 BREAKING: The Senate has CONFIRMED Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services.
The confirmation process was marked by intense scrutiny of Kennedy’s record and policy positions. The Senate Finance Committee advanced his nomination last Tuesday with a narrow 14-13 vote.
Senator Bill Cassidy (R-La.), a physician and key swing vote, played a decisive role in moving Kennedy’s nomination forward. Cassidy, who has represented Louisiana in the Senate since 2014, broke with some in his party to support the nominee.
The full Senate advanced Kennedy’s nomination on Wednesday following a successful cloture vote of 53 to 47.
During his confirmation process, Kennedy worked to distance himself from past remarks that raised doubts about vaccine safety.
Despite the controversy, he managed to secure enough backing from Republicans to push his nomination forward.
As head of HHS, Kennedy will oversee federal health policy, including responses to public health crises, health care regulations and medical research funding. His tenure is expected to bring significant policy debates, particularly regarding vaccine policy, regulatory oversight and public health initiatives.
With Kennedy now confirmed, all eyes will be on how he navigates key health policy challenges in the months ahead.
This is a breaking news story. Please check back for updates.
The White House, Public domain, via Wikimedia Commons
President Donald Trump has selected Dr. Heidi Overton, a senior White House domestic policy adviser and physician, to lead the Food and Drug Administration as the agency confronts battles over vaccines, drug prices, food additives, and abortion medication.
Trump announced the nomination Wednesday, describing Overton as a trusted problem-solver who would accelerate medical innovation, lower prescription costs, and advance Health and Human Services Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” agenda.
Overton currently serves as deputy director of the White House Domestic Policy Council, where she has helped formulate and promote several of the administration’s most consequential health initiatives.
BREAKING: President Trump picks Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration. https://t.co/fGVJ7TNQjt
If confirmed by the Senate, she would succeed Dr. Marty Makary, who left the agency in May after a turbulent tenure marked by internal disputes and disagreements over the direction of federal health policy.
Kyle Diamantas, who previously led the FDA’s Human Foods Program, is serving as acting commissioner.
A Physician With Deep White House Ties
Overton is a board-certified physician in public health and general preventive medicine. She earned her medical degree from the University of New Mexico School of Medicine and a doctorate in clinical investigation from the Johns Hopkins Bloomberg School of Public Health.
She previously trained as a general surgery resident at Johns Hopkins and advocated for greater price and quality transparency in health care.
During medical school, then-New Mexico Gov. Susana Martinez appointed Overton to the University of New Mexico Board of Regents, where she held voting and fiduciary responsibility for the university and its health system.
Overton first entered the Trump White House as a fellow in 2019, working in the Office of American Innovation and on the Domestic Policy Council. Between Trump’s terms, she served as chief policy officer at the America First Policy Institute and helped lead its Center for a Healthy America.
Her biography from the conservative organization emphasizes her work on health-care transparency, fentanyl, public health and policies designed to give patients greater control over medical decisions.
The appointment would place a committed administration loyalist at the head of an agency that regulates products representing roughly one-fifth of American consumer spending.
Overton Helped Shape Trump’s Health Agenda
Overton has appeared alongside Trump during major health policy announcements, including the administration’s efforts to negotiate “most favored nation” agreements with drug companies. The policy seeks to tie American prescription prices to the lower prices paid in other developed countries.
She was also involved in Trump’s controversial effort to revise the childhood vaccination schedule and separate the combined measles, mumps and rubella vaccine into three individual shots.
Major medical organizations have generally supported the combined MMR vaccine, which has been used for decades and reduces the number of clinical visits and injections required for full immunization. Critics fear that splitting the vaccine could create delays and lower vaccination rates.
Overton’s role in the policy is likely to become a focus of her Senate confirmation hearing, particularly as lawmakers question how she would handle pressure from Kennedy and other administration figures skeptical of established federal vaccine recommendations.
Trump praised Overton as a “rockstar” who would advance medical cures, innovation and lower drug prices.
Kennedy also supports the nomination, giving Overton an important ally inside the Department of Health and Human Services, which oversees the FDA.
Difficult Issues Await New Commissioner
The next FDA commissioner will inherit an unusually difficult collection of unfinished projects.
The agency continues to face pressure over its regulation of COVID-19 vaccines and other immunizations, including questions about which populations should receive updated shots and what evidence manufacturers must provide.
Medication abortion will present another immediate test. Pro-life organizations want the FDA to impose tighter restrictions on mifepristone, including limits on prescriptions issued through telehealth and pills delivered through the mail.
Overton has previously used the term “teleabortion” when discussing remote access to abortion medication, drawing concern from abortion-rights organizations that expect her to revisit the drug’s rules.
The FDA must also determine how aggressively it will regulate ultraprocessed foods, chemical additives, and synthetic dyes. Those issues are central to Kennedy’s MAHA movement but can conflict with the deregulatory approach traditionally favored by Republican lawmakers and industry groups.
Other pending questions involve flavored electronic cigarettes, peptide treatments, psychedelics, antidepressant warnings, and efforts to shorten the approval process for new drugs.
Overton would therefore have to balance three competing forces: Trump’s desire for faster approvals and lower prices, Kennedy’s campaign against corporate influence in food and medicine, and Republican demands for reduced federal regulation.
Management Experience Likely to Draw Scrutiny
Overton’s supporters point to her medical education, policy background, and proximity to presidential decision-making. They argue that she understands Trump’s priorities and can coordinate more effectively with the White House than an outside nominee.
Critics are expected to focus on her limited experience running an organization comparable to the FDA.
The agency employs thousands of scientists, physicians, inspectors, lawyers, and regulatory specialists. It oversees prescription drugs, medical devices, vaccines, tobacco products, much of the nation’s food supply, and other consumer goods.
Axios reported before her selection that some health policy observers worried Overton’s nomination could unsettle FDA career employees and pharmaceutical investors, while other potential candidates possessed more direct executive management experience.
The criticism will likely feature prominently when she appears before the Senate Health, Education, Labor and Pensions Committee.
Makary, Overton’s predecessor and a former Johns Hopkins colleague, was confirmed in March 2025 by a 56-44 Senate vote. Overton will seek confirmation from a chamber still controlled by Republicans but divided over the administration’s vaccine policies.
Her nomination signals that Trump wants the FDA led by someone already embedded in his White House rather than an agency insider or pharmaceutical executive.
If the Senate agrees, Overton will take control of one of the federal government’s most powerful scientific agencies — and become responsible for turning the administration’s sprawling health agenda into enforceable policy.
President Donald Trump participates in a welcome ceremony with Saudi Crown Prince Mohammed Bin Salman Al Saud at the Royal Court Palace in Riyadh, Saudi Arabia, Tuesday, May 13, 2025. (Official White House Photo by Daniel Torok)
President Donald Trump will have his annual medical checkup at a hospital near Washington on May 26, the White House said Monday night.
The oldest person ever inaugurated as President, Trump, turns 80 in June. Trump traveled to China for a summit with that country’s leader, Xi Jinping this week.
Read the full statement from the White House:
President Donald J. Trump will visit Walter Reed National Military Medical Center on May 26 for his annual dental and medical evaluations, and to visit with the men and women of the military. This will include the President’s routine annual dental and medical assessments as part of his regular preventive health care. The President will also spend time with service members and staff at Walter Reed in recognition of their service, professionalism, and dedication to the nation. Additional details regarding the President’s schedule will be released at a later date.
In March, the White House doctor said the president was taking a prescription “preventative skin treatment” to treat irritation on his neck.
Last July, the White House said Trump had been diagnosed with chronic venous insufficiency, a common condition tied to swelling in the legs, but that doctors had otherwise found the president to be in “excellent health.”
White House Chief of Staff Susie Wiles delivers remarks during the Memorial Service for Charlie Kirk at State Farm Stadium in Glendale, Arizona, Sunday, September 21, 2025.(Official White House Photo by Daniel Torok)
White House Chief of Staff Susie Wiles announced Wednesday that she is cancer-free, six months after disclosing her early-stage breast cancer diagnosis.
“After a medical appointment at the Mayo Clinic this week, my pathology results came back clear,” Wiles wrote in a post on X. “I am cancer free.”
Some personal news I’m grateful to share. After a medical appointment at the Mayo Clinic this week, my pathology results came back clear.
I am cancer free.
Thank you to my family, friends, doctors, and everyone who prayed for me, checked in, and supported me along the way.
Wiles thanked her family, friends, doctors and those who prayed for and supported her during treatment.
She also offered “a special thank you” to President Donald Trump for his “unwavering support,” adding that she would continue working to advance his America First agenda.
Wiles revealed her diagnosis in March and continued carrying out her duties during treatment. She returned to work shortly after undergoing a cancer-related medical procedure at the Mayo Clinic earlier this week, CBS News reported.
Gage Skidmore from Surprise, AZ, United States of America, CC BY-SA 2.0 , via Wikimedia Commons
White House press secretary Karoline Leavitt is expected to welcome her second child this week, adding a personal milestone to a tenure already defined by firsts. At 28, she is the youngest press secretary in U.S. history and the first known to serve in the role while pregnant.
Her upcoming leave raises practical questions for the administration, including how long she plans to step away and how the White House will manage one of its most visible daily responsibilities in her absence.
Unclear timeline for leave
A White House official said it’s not yet clear how much time Leavitt will take off after the birth. Like other federal employees, she is generally entitled to up to 12 weeks of paid parental leave. Whether she uses the full period remains an open question.
That uncertainty leaves the briefing schedule in a flexible position, with no firm timeline for her return to the podium.
No interim press secretary planned
Instead of naming a temporary replacement, the White House plans to rely on a rotating group of officials to handle press briefings. That group could include President Donald Trump and Vice President JD Vance, an approach that would break from the more traditional model of a single, consistent spokesperson.
The decision signals a willingness to experiment, but it also introduces the possibility of mixed messaging. Different officials bring different styles, and consistency has long been a priority in managing daily communication with the press.
Family life in the public eye
Leavitt first announced her pregnancy in December, sharing that she and her husband, Nicholas Riccio, were expecting a daughter. Their first child, Niko, was born in July 2024 and has already appeared in the briefing room during special events.
In a social media post after Christmas, Leavitt said she was looking forward to becoming a “girl mom” and described the coming year as meaningful for her family. She also pointed to what she called a supportive, pro-family culture within the White House, crediting both President Trump and chief of staff Susie Wiles.
JUST IN: Karoline Leavitt speaks to the press for what is likely the last time before she has her second baby:
“This will likely be my last gaggle for some time.”
“As you can see, I’m about ready to have a baby any minute, so I’ll see you guys very soon.”
Leavitt continued her duties throughout the pregnancy, rarely stepping back from the demands of the role. That includes leading daily briefings and serving as a central voice for the administration during a busy stretch of domestic and international developments.
Her tenure has also brought changes to the structure of the briefing room. Most notably, she introduced a designated space for “new media,” giving podcasters, independent journalists, and digital creators a more visible presence.
She has often called on those voices early in briefings, a shift away from the traditional dominance of legacy outlets.
A test for a changing briefing room
Leavitt’s temporary absence could put that evolving setup to the test. With multiple officials rotating through the podium, the tone and priorities of briefings may shift from day to day.
That variability may not matter much during quieter periods. But in moments that require clear, unified messaging, it could become more noticeable.
Balancing public service and private life
For now, the focus remains on a personal milestone. Even in a role tied closely to national politics and constant scrutiny, family life continues alongside the job.
Leavitt’s situation underscores a familiar challenge in Washington: balancing the demands of public service with life outside the office. It’s not unique, but it’s rarely this visible.
Her return, whenever it comes, will likely bring the operation back to a more familiar rhythm. Until then, the White House is preparing to adjust on the fly.
Gage Skidmore from Surprise, AZ, United States of America, CC BY-SA 2.0 , via Wikimedia Commons
President Donald Trump set off another round of social media speculation Friday after cameras caught what looked like copious amounts of makeup on his hand during public appearances in Washington.
A patch of foundation, slightly lighter than his skin tone, was visible while he toured an exhibit at The People’s House museum. Later that day, during the World Cup 2026 draw event at The Kennedy Center, Trump kept one hand over the other while addressing the crowd — a move that didn’t go unnoticed by outlets like The Daily Beast, which pointed out the recurring appearance of cosmetic cover.
This isn’t the first time similar images have made the rounds. Observers cited previous instances following Trump’s meetings with French President Emmanuel Macron in February, European Commission President Ursula von der Leyen in July, and U.K. Prime Minister Keir Starmer.
Asked about the chatter, White House Press Secretary Karoline Leavitt brushed aside the tabloid-style coverage.
“President Trump is a man of the people, and he meets more Americans and shakes more hands on a daily basis than any other president in history,” Leavitt told The Independent Saturday. “His commitment is unwavering, and he proves that every single day.”
The renewed scrutiny follows last month’s stir over photos showing discoloration and swelling in Trump’s legs during a FIFA Club World Cup appearance. The White House later confirmed the president has chronic venous insufficiency — a common circulatory condition in which blood pools in the veins due to weakened valves.
According to the Cleveland Clinic, the condition can lead to discomfort but is manageable. Leavitt said Trump isn’t in pain and hasn’t required treatment or changes to his daily routine.
In April, White House physician Capt. Sean Barbabella declared the president in “excellent cognitive and physical health” after his annual checkup. He attributed bruising on Trump’s hands to aspirin therapy, a standard precaution for heart health.
FULL TRANSPARENCY: Karoline Leavitt addresses speculation about President Trump’s bruised hand and swollen ankles pic.twitter.com/sKTgb9PYqT
The White House, Public domain, via Wikimedia Commons
Former Trump family member Vanessa Trump revealed Wednesday that she has been diagnosed with breast cancer, prompting an outpouring of support from relatives, friends, and supporters connected to President Donald Trump’s extended family circle.
The 48-year-old former model and television personality shared the news in an emotional Instagram statement, describing the diagnosis as an unexpected challenge while emphasizing that she remains optimistic.
“I’ve recently been diagnosed with breast cancer,” Vanessa wrote. “While this isn’t news anyone expects, I’m working closely with my medical team on a treatment plan.”
Vanessa also revealed that doctors performed a procedure earlier this week, though she did not provide additional details regarding the nature of the procedure or the stage of her diagnosis. She said she is relying heavily on her family and close loved ones as she begins treatment.
“I am staying focused and hopeful while surrounded by the love and support of my family, my kids, and those closest to me,” she wrote.
Vanessa concluded the statement by thanking supporters for their encouragement and asking for privacy while she focuses on recovery.
The announcement quickly drew public reactions from members of the Trump family.
President Trump’s daughter, Ivanka Trump, posted a heartfelt response beneath Vanessa’s announcement.
“Praying for your continued strength and a swift recovery. Love you mama,” Ivanka wrote.
Vanessa’s daughter, Kai Trump, also shared an emotional message, calling her mother “the strongest person I know” in a social media tribute that resonated with supporters.
Additional support reportedly came through social media engagement from other members of the Trump family as Vanessa’s announcement spread online.
Vanessa was married to Donald Trump Jr. for more than a decade before the pair divorced in 2018. The former couple share five children together and have largely maintained a cooperative relationship centered around family matters.
In recent years, Vanessa has kept a lower public profile compared to many members of the Trump family. However, she returned to headlines after legendary golfer Tiger Woods publicly confirmed their relationship in 2025. The two have since been seen together at family events and golf-related appearances.
Her diagnosis sparked an immediate wave of support online, with many supporters offering prayers and well wishes as she begins what could be a difficult health battle.
MAHA Year One: How Trump & RFK Jr. Are Rebuilding American Health
For decades, Americans were told a story about their health that no longer matched reality. We were assured that food was safe, that regulators were vigilant, that medical advice was insulated from politics and profit, and that rising chronic disease was an unfortunate but unavoidable byproduct of modern life. Meanwhile, the health of the nation deteriorated in plain sight. Obesity climbed year after year. Childhood chronic disease became common rather than exceptional. Autism rates surged. Cancer diagnoses among children rose. By the time President Trump returned to office, 76.4% of Americans were living with at least one chronic disease. Eight out of 10 children could not qualify for military service. What should have been treated as a civilizational emergency was instead normalized, until that long-running failure of honesty and accountability culminated during the COVID-19 pandemic, when public health leaders abandoned transparency, misled the public, and, under Dr. Fauci’s direction, shattered trust in medical professionals and the institutions meant to serve them.
The collapse of trust that followed COVID did not occur in a vacuum. It was the culmination of years of regulatory capture, scientific arrogance, and a public health establishment that confused authority with truth. Americans were ordered, not persuaded. Dissent was pathologized. Data was selectively presented. Vaccine policy was enforced through mandate rather than transparency. Dr. Fauci became the symbol of an anti-science regime that claimed infallibility while revising its claims in real time. When institutions insist on obedience while refusing accountability, trust does not merely erode; it implodes.
It is against this backdrop that the Make America Healthy Again initiative must be understood. MAHA is not a branding exercise or a partisan slogan. It is a course correction. President Trump’s decision to place Robert F. Kennedy Jr. at the helm of HHS was not an appeal to nostalgia or name recognition. It was an explicit rejection of the managerial consensus that presided over the chronic disease explosion. The mandate was simple and radical: identify root causes, dismantle regulatory capture, and tell the truth even when it disrupts powerful interests.
Skeptics ask whether one year can matter. The answer depends on what one expects a first year to do. MAHA was never going to reverse decades of metabolic, environmental, and institutional decay overnight. Its purpose was to reorient the system, establish credibility, and force long-delayed questions back into the open. By that standard, the first year has been historic.
Start with the scope of institutional change. President Trump signed an executive order establishing the MAHA Commission, chaired by Secretary Kennedy, with a singular focus on chronic disease. For the first time in generations, chronic illness was treated not as an actuarial inevitability but as a policy failure demanding investigation. This alone marked a break with orthodoxy. Under previous administrations, chronic disease spending rose to $1.3T annually while prevention remained an afterthought. When Kennedy notes that the federal government once spent essentially nothing on chronic disease, he is not making a rhetorical point. He is diagnosing a structural blind spot.
The results are already visible. Thirty-seven states have enacted legislation advancing MAHA-aligned reforms. Nearly 100 MAHA-related bills have passed nationwide. Eighteen states secured SNAP waivers to restrict taxpayer-funded junk food purchases that directly fuel obesity and diabetes. These are not symbolic victories. They are structural incentives aligned with public health rather than industry convenience.
Food policy has been the most visible arena of reform, and for good reason. The American diet did not become toxic by accident. It was engineered through regulatory loopholes that allowed synthetic additives to enter the food supply under the GRAS standard with minimal oversight. MAHA moved quickly to overhaul this system. Agreements now cover roughly 40% of the food industry, committing to remove petroleum-based synthetic dyes. The dairy industry has pledged to eliminate artificial dyes from ice cream by 2028. These changes matter because they reset norms. Once voluntary reform becomes expected, resistance collapses.
The same logic applies to infant health. Operation Stork Speed was launched to expand access to safe and nutritious infant formula while removing heavy metals that had no business entering baby food in the first place. For parents who watched institutions minimize legitimate safety concerns during COVID, this shift toward precaution and transparency has been decisive in rebuilding trust.
Critics often ask whether MAHA is anti-science. The premise is backward. MAHA is anti-dogma. It insists that science earns authority through openness, replication, and humility. This is why vaccine policy has been reframed around informed consent and gold standard trials rather than mandates. Honesty about uncertainty is not weakness. It is the precondition of credibility. Public trust returns when institutions stop pretending to be omniscient.
This emphasis on trust extends beyond food and vaccines. HHS issued guidance restoring biological truth, recognizing that there are two sexes, male and female. This was not culture war theater. Medicine depends on biological reality. When institutions deny observable facts for ideological reasons, patients notice. Restoring clarity restores confidence.
MAHA’s critics also underestimate the importance of state-level experimentation. Utah’s decision to ban added fluoride in public drinking water did not impose a national mandate. It reopened a conversation that had been closed by bureaucratic inertia. Communities are once again allowed to weigh risks and benefits rather than defer to outdated consensus.
Health care delivery itself has not been ignored. Prior authorization has long functioned as a hidden tax on patients and physicians, delaying care while enriching intermediaries. Secretary Kennedy and CMS Administrator Oz secured industry commitments to streamline this process across health plans. Less paperwork means faster treatment and lower burnout. These are the reforms patients feel immediately.
Drug pricing has followed the same philosophy. President Trump’s most favored nation order is being rapidly implemented to align U.S. prescription drug prices with those paid abroad. This is not price control masquerading as populism. It is a refusal to subsidize global markets at the expense of American patients. Lower prices are a public health intervention.
Physical health has returned to the cultural mainstream as well. The Pete and Bobby Challenge, launched by Secretary Kennedy alongside Defense Secretary Hegseth, did something that countless white papers failed to do. It made fitness visible again. A nation where most children cannot meet basic physical standards is not merely unhealthy. It is vulnerable.
The MAHA Commission’s release of the Make Our Children Healthy Again strategy, outlining more than 120 initiatives, signaled that childhood chronic disease is no longer being treated as a mystery or a taboo. New data linking rising thyroid and kidney cancers among children demands answers. Autism rates demand answers. MAHA has made clear that asking these questions is not forbidden. It is required.
Perhaps the most underestimated achievement of the first year is cultural rather than regulatory. Trust is returning because institutions are speaking plainly. The public understands that special interests once thrived behind closed doors. They know they were sold better cigarettes and sugar smacks with a health halo. What they demanded in 2024 was not perfection. It was honesty.
President Trump and Secretary Kennedy have delivered the first credible attempt in decades to dismantle the alliance between bureaucratic power and corporate profit that hollowed out public health. The appointments at NIH, FDA, and CMS reflect this shift. These are not partisan enforcers. They are reformers tasked with ending capture and restoring the mission.
No serious observer should claim that the work is finished. Chronic disease did not emerge in one year, and it will not be eliminated in one term. But trajectories matter. Incentives matter. Trust matters most of all. After years in which Americans were told to comply and not question, MAHA has reopened the social contract between the public and medicine.
Public health cannot function without consent. Consent requires trust. Trust requires truth. That is the chain MAHA is rebuilding. It is why the first year matters. Not because every problem has been solved, but because the system has finally been pointed in the right direction.
If you enjoy my work, please subscribe: https://x.com/amuse.
Sponsored by the John Milton Freedom Foundation, a nonprofit dedicated to helping independent journalists overcome formidable challenges in today’s media landscape and bring crucial stories to you.
Sponsored
Arizona is at risk — and Turning Point needs you NOW. Your donation funds ballot chasers and wins critical state races. Donate TODAY to help save America — one state at a time.